1. Home
  2. IPHA vs IONR Comparison

IPHA vs IONR Comparison

Compare IPHA & IONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • IONR
  • Stock Information
  • Founded
  • IPHA 1999
  • IONR 2001
  • Country
  • IPHA France
  • IONR Australia
  • Employees
  • IPHA N/A
  • IONR N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • IONR
  • Sector
  • IPHA Health Care
  • IONR
  • Exchange
  • IPHA Nasdaq
  • IONR Nasdaq
  • Market Cap
  • IPHA 191.0M
  • IONR 171.1M
  • IPO Year
  • IPHA 2019
  • IONR N/A
  • Fundamental
  • Price
  • IPHA $2.28
  • IONR $4.20
  • Analyst Decision
  • IPHA Strong Buy
  • IONR
  • Analyst Count
  • IPHA 1
  • IONR 0
  • Target Price
  • IPHA $11.50
  • IONR N/A
  • AVG Volume (30 Days)
  • IPHA 5.5K
  • IONR 8.7K
  • Earning Date
  • IPHA 09-12-2024
  • IONR 01-01-0001
  • Dividend Yield
  • IPHA N/A
  • IONR N/A
  • EPS Growth
  • IPHA N/A
  • IONR N/A
  • EPS
  • IPHA N/A
  • IONR N/A
  • Revenue
  • IPHA $36,202,722.00
  • IONR N/A
  • Revenue This Year
  • IPHA N/A
  • IONR N/A
  • Revenue Next Year
  • IPHA $105.84
  • IONR N/A
  • P/E Ratio
  • IPHA N/A
  • IONR N/A
  • Revenue Growth
  • IPHA 6.88
  • IONR N/A
  • 52 Week Low
  • IPHA $1.81
  • IONR $2.90
  • 52 Week High
  • IPHA $3.15
  • IONR $6.50
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 50.55
  • IONR 57.27
  • Support Level
  • IPHA $2.27
  • IONR $3.76
  • Resistance Level
  • IPHA $2.41
  • IONR $4.48
  • Average True Range (ATR)
  • IPHA 0.11
  • IONR 0.28
  • MACD
  • IPHA -0.00
  • IONR 0.03
  • Stochastic Oscillator
  • IPHA 52.94
  • IONR 51.68

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About IONR ioneer Ltd

Ioneer Ltd is a mineral exploration company. The company's focus is on the Rhyolite Ridge Lithium-Boron Project located in Nevada, USA. Geographically, the group has a business presence in Australia and North America. The company's focus is to develop a U.S. based source of lithium and boron that can be extracted in an environmentally and socially responsible manner, providing two materials that are essential to achieve a sustainable future for the planet.

Share on Social Networks: